Pharmafile Logo
Pharmafocus logo
Advanced Search

Latest Feature Articles

ai_graphic

The future is now: The transformative power of AI

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | AI, Exscientia, GSK, GlaxoSmithKline, artificial intelligence, drug development, pharma

With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …

Feature
20170105_studio_profielfoto___marco_avila_05_web

Working Life: Marco Avila, Vice President of Medical Affairs, Teva Europe

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Teva, Working Life

Pharmafile.com met with Marco Avila, Vice President of Medical Affairs at Teva Europe to discuss his life in the industry, …

Feature
cambridge_biomedical_campus

Delivering the life sciences agenda: Easy as ABC

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Life sciences strategy, biotech, brexit, drugs, pharma, pharmaceutical

Andrew Blevins and Andrew Carrington of Liberty Property Trust and Countryside Properties explain how organisations at the Cambridge Biomedical Campus …

Feature
nicolas_raymond

The measurement underpinning government goals for UK life sciences

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Life Sciences Industrial Strategy, brexit, john bell, life sciences, pharma

Michael Adeogun, Head of Life Sciences and Health at National Physical Laboratory, discusses the importance of effective measurement for the …

Feature
sunrise-1756274_960_720

Riding the wave: The FDA and real world evidence

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | biotech, drugs, pharma, pharmaceutical, real world evidence

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …

Feature
heartbeat-3077960_960_720

Seizing opportunities in the next steps for real world evidence

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | biotech, drugs, pharma, pharmaceutical

Real world evidence is high on the agenda at many conferences, as people mull over the possibilities that it may …

Feature
shutterstock_158366573

The PROs and cons of pushing patient centricity

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | feature, patient reported outcomes, pharma

As the pharmaceutical industry places increasing weight on the importance of patient-reported outcomes in securing approvals, Ben Hargreaves examines how …

Feature
2018

Seven pharma trends for 2018

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | 2018, M&A, MA, biosimilars, collaborations, digital pharma, emerging markets, patient centricity, pharma, pricing

Pharmafile.com looks ahead to signpost what we expect will be the key industry trends through the course of 2018.The value of …

Feature
attribution-icon-2888829_640

The rare disease climate in Europe

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | biotech, drugs, pharma, pharmaceutical, rare disease

Continuing on from this week’s earlier feature on the rare disease situation in the US, Pharmafile moves its attention onto …

Feature
rare-disease-2888820_960_720

Rare disease medicines access faces a perfect storm

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | biotech, drugs, pharma, pharmaceutical, rare disease

With access to rare disease treatments coming under increasing attention, both in the EU and the US, Pharmafile.com took the …

Feature
fullsizerender_2_rav

Working Life: Dr Rav Seeruthun, Medical Director of Roche UK

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Roche, biotech, drugs, pharma, pharmaceutical

Pharmafile.com sat down with Dr Rav Seeruthun, Medical Director of Roche UK, to discuss his career thus far and the lessons …

Feature
hands-600497_960_720

To succeed in emerging market medicine, anticipation and innovation are essential

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Abbott, biotech, drugs, emerging markets, pharma, pharmaceutical

Andrew Lane, Executive Vice President of Established Pharmaceuticals at Abbott, discusses the key steps to be taken when reaching out …

Feature
dna-163466

Getting precision treatments over the line will be a team effort, not an individual bolt for glory

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Prostate Cancer UK, biotech, drugs, pharma, pharmaceutical, prostate cancer

We’ve finally reached the starter’s block when it comes to precision medicine approaches to prostate cancer, but Dr Matthew Hobbs, …

Feature
vaccination-2722937_960_720

The race to find an effective dengue vaccine

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Takeda, biotech, dengue, drugs, pharma, pharmaceutical

Derek Wallace, Global Dengue Program Head at Takeda Vaccine Business Unit, discusses the recent Phase 2 results showing its vaccine …

Feature
shutterstock_212432119

What’s driving change in drug discovery and development?

Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing | Big Data, Lhasa limited, charity, drug discovery, pharma, pharmacovigilance

Dr Chris Barber, CEO of not-for-profit organisation and educational charity Lhasa Limited, discusses new innovations and ideas that are set …

Feature
Load more Feature Articles
The Gateway to Local Adoption Series

Latest content

Siemens Healthineers opens 10m euro R&D centre for laboratory equipment in Ireland

February 19, 2026

Everdrone announces new board of directors to drive expansion

February 19, 2026

Regeneron announces presentations of new data on Eylea HD for retinal disease

February 18, 2026

Indegene completes acquisition of Cake Health

February 18, 2026

Gedeon Richter UK acquires rights to schizophrenia treatment Reagila from Recordati Pharmaceuticals

February 17, 2026